Skip to content

Study Details

Expanded Access Treatment with Open-Label Pegunigalsidase Alfa for Fabry Patients

(IRB#: IRB_00140105)

Expanded Access Treatment with Open-Label Pegunigalsidase Alfa for Fabry Patients.

I AM INTERESTED

  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Unpaid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Will I be paid for my time?

No

For more information contact:

Carrie Bailey

carrie.bailey@hsc.utah.edu

  801-587-3605

IRB#: IRB_00140105

PI: Nicola Longo

Department: PEDIATRIC GENETICS

Approval Date: 2021-04-07 06:00:00

Specialties: Pediatric Genetics

Last Updated: 6/8/23